Given the purported salesforce synergy AGN has claimed for Botox and Levadex, I would've thought Levadex for 3/4 of a year would generate at least a penny of EPS. However, AGN has a history of lowballing EPS numbers, so it's hard to know how much they actually had baked in for Levadex in 2013.
Market Data 
Markets 
AI
